Yorktown Management & Research Company’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
AI
Yorktown Management & Research Company's CRL Position: Q3 2025 in Review
Yorktown Management & Research Company sold out of Charles River Laboratories (CRL) in Q3 2025, closing a stake of 1,800 shares — an estimated $273K sold.
Yorktown Management & Research Company first reported a position in CRL in Q1 2018 and held it in 25 quarters. The position peaked at $743K in Q3 2021. 554 funds tracked by Wall St. Rank hold CRL as of Q3 2025.
- Yorktown Management & Research Company reported no remaining Charles River Laboratories position as of Q3 2025 after selling out during the quarter.
- Yorktown Management & Research Company sold 1,800 Charles River Laboratories shares in Q3 2025, an estimated $273K.
- Yorktown Management & Research Company first reported a position in Charles River Laboratories in Q1 2018 and held it in 25 quarters.
- Yorktown Management & Research Company's Charles River Laboratories position peaked at $743K in Q3 2021.
- 554 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2025.
Based on Yorktown Management & Research Company's 13F filing for Q3 2025, filed 29 Oct 2025.